Cita APA

Hochmair, M. J., Buder, A., Schwab, S., Burghuber, O. C., Prosch, H., Hilbe, W., . . . Filipits, M. (2018). Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib. Target Oncol.

Chicago Style Citation

Hochmair, Maximilian J., Anna Buder, Sophia Schwab, Otto C. Burghuber, Helmut Prosch, Wolfgang Hilbe, Agnieszka Cseh, Richard Fritz, i Martin Filipits. "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients With Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib." Target Oncol 2018.

Cita MLA

Hochmair, Maximilian J., et al. "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients With Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib." Target Oncol 2018.